Frazier Life Sciences Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $346M | Hold |
6,795,121
| – | – | 13.83% | 1 |
|
|
2025
Q1 | $306M | Buy |
6,795,121
+224,729
| +3% | +$10.1M | 13.99% | 2 |
|
|
2024
Q4 | $272M | Hold |
6,570,392
| – | – | 11.28% | 2 |
|
|
2024
Q3 | $256M | Buy |
6,570,392
+75,000
| +1% | +$2.93M | 10.27% | 1 |
|
|
2024
Q2 | $222M | Hold |
6,495,392
| – | – | 10.39% | 2 |
|
|
2024
Q1 | $163M | Hold |
6,495,392
| – | – | 6.88% | 3 |
|
|
2023
Q4 | $192M | Buy |
6,495,392
+25,000
| +0.4% | +$738K | 10.25% | 1 |
|
|
2023
Q3 | $204M | Buy |
6,470,392
+2,110,285
| +48% | +$66.7M | 13.58% | 1 |
|
|
2023
Q2 | $113M | Buy |
4,360,107
+500,000
| +13% | +$12.9M | 6.74% | 6 |
|
|
2023
Q1 | $92.7M | Hold |
3,860,107
| – | – | 6.71% | 5 |
|
|
2022
Q4 | $75.3M | Buy |
3,860,107
+32,326
| +0.8% | +$630K | 4.68% | 9 |
|
|
2022
Q3 | $80.4M | Buy |
3,827,781
+260,869
| +7% | +$5.48M | 6.19% | 6 |
|
|
2022
Q2 | $69.4M | Hold |
3,566,912
| – | – | 6.55% | 4 |
|
|
2022
Q1 | $78.5M | Buy |
+3,566,912
| New | +$78.5M | 6.69% | 3 |
|